# Arcus Biosciences, Inc. (RCUS) RCUS faces headwinds as STAR-221 study is discontinued and TIGIT therapy efficacy concerns rise. Analyst downgrades also contribute to negative price action. ### About Arcus Biosciences, Inc. Arcus Biosciences, Inc. is a biotechnology company focused on developing novel cancer immunotherapies. Arcus Biosciences, Inc. uses the ticker $RCUS for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights - Arcus Biosciences, Inc. (RCUS) trading volume is up 24.33% from the previous week. - Arcus Biosciences, Inc. (RCUS) social dominance is up 2125% from the previous week. - Arcus Biosciences, Inc. (RCUS) sentiment is up 100% from the previous week. - Arcus Biosciences, Inc. (RCUS) posts created is up 116.67% from the previous week. ### Price: $18.90  [Price 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/close.tsv) The current price action for RCUS is negative, with a significant drop attributed to the discontinuation of the Phase [--] STAR-221 study and broader concerns about TIGIT therapy efficacy, despite a recent 52-week high and some analyst upgrades. 24-Hour: -5.21% 7-Day: -10.03% 30-Day: -13.21% 1-Year High: $26.10 on 2025-11-28 1-Year Low: $6.90 on 2025-04-04 ### AltRank: [-----]  [AltRank 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/alt_rank.tsv) Arcus Biosciences, Inc. (RCUS) is currently AltRank #1,154 based on combined combined social and market metrics Daily Average: [-----] [--] Week: [-----] +1,184 [--] Month: [-----] +505 [--] Months: [-----] +742 [--] Year: [-----] +1,020 1-Year High: [-----] on 2026-02-06 1-Year Low: [--] on 2025-12-28 ### Galaxy Score: [--]  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/galaxy_score.tsv) Current Value: [--] Daily Average: [--] [--] Week: [--] [---] [--] Month: [--] [---] 1-Year High: [--] on 2026-01-13 1-Year Low: [--] on 2026-01-16 ### Engagements: [-----] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/interactions.tsv) Current Value: [-----] Daily Average: [-----] [--] Week: [-----] -74% [--] Month: [------] +19% [--] Months: [-------] +57% [--] Year: [-------] -4.50% 1-Year High: [------] on 2025-11-25 1-Year Low: [--] on 2025-09-14 Engagements by network (24h): News: [--] Reddit: [--] TikTok: [--] X: [---] YouTube: [--] ### Mentions: [--] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/posts_active.tsv) Current Value: [--] Daily Average: [--] [--] Week: [--] +9.10% [--] Month: [---] +76% [--] Months: [-----] +23% [--] Year: [-----] +172% 1-Year High: [---] on 2025-06-28 1-Year Low: [--] on 2025-09-14 Mentions by network (24h): News: [--] Reddit: [--] TikTok: [--] X: [--] YouTube: [--] ### Creators: [--] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/contributors_active.tsv) [--] unique social accounts have posts mentioning Arcus Biosciences, Inc. (RCUS) in the last [--] hours which is up 29% from [--] in the previous [--] hours Daily Average: [--] [--] Week: [--] +9.40% [--] Month: [---] +31% [--] Months: [---] -38% [--] Year: [-----] +201% 1-Year High: [---] on 2025-06-28 1-Year Low: [--] on 2025-09-14 ### Sentiment: 75%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/sentiment.tsv) Current Value: 75% Daily Average: 75% [--] Week: 100% +50% [--] Month: 50% +22% [--] Months: 50% -38% [--] Year: 50% -50% 1-Year High: 100% on 2025-02-15 1-Year Low: 3% on 2025-12-07 Most Supportive Themes: - Positive Social Media Trends: (75%) Social dominance, Galaxy Score, and sentiment have all seen significant increases, indicating growing positive attention and engagement. - Increased Content Creation: (25%) The number of posts about Arcus Biosciences has risen over the past [--] months and [--] year, suggesting sustained interest. Most Critical Themes: - Discontinuation of STAR-221 Study: (60%) The Phase [--] STAR-221 study has been discontinued, raising concerns about TIGIT therapy efficacy. - Analyst Downgrades: (40%) Arcus Biosciences (RCUS) was among the stocks that received downgrades on February 12th, contributing to negative price action. ### Social Dominance: 0.00225%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/social_dominance.tsv) Current Value: 0.00225% Daily Average: 0.00474% [--] Week: 0.0089% +0.0085% [--] Month: 0.0031% -0.0012% [--] Months: 0.0031% -0.0056% [--] Year: 0.0031% -0.001% 1-Year High: 0.032% on 2025-06-28 1-Year Low: 0.0002% on 2025-09-14 ### Market Dominance: 0.00265%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/market_dominance.tsv) Current Value: 0.00265% Daily Average: 0% 1-Year High: 0.12% on 2026-02-06 1-Year Low: 0.00265% on 2026-02-14 ### Market Cap: $2,340,943,901  [Market Cap 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/market_cap.tsv) Current Value: $2,340,943,901 Daily Average: $2,795,082,619 [--] Week: $2,338,469,330 -10% [--] Month: $2,340,943,901 -13% 1-Year High: $3,229,314,790 on 2025-11-28 1-Year Low: $2,340,943,901 on 2026-02-13 Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
RCUS faces headwinds as STAR-221 study is discontinued and TIGIT therapy efficacy concerns rise. Analyst downgrades also contribute to negative price action.
Arcus Biosciences, Inc. is a biotechnology company focused on developing novel cancer immunotherapies.
Arcus Biosciences, Inc. uses the ticker $RCUS for trading. Listed in the Stocks category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The current price action for RCUS is negative, with a significant drop attributed to the discontinuation of the Phase [--] STAR-221 study and broader concerns about TIGIT therapy efficacy, despite a recent 52-week high and some analyst upgrades.
24-Hour: -5.21% 7-Day: -10.03% 30-Day: -13.21%
1-Year High: $26.10 on 2025-11-28
1-Year Low: $6.90 on 2025-04-04
AltRank 24-Hour Time-Series Raw Data
Arcus Biosciences, Inc. (RCUS) is currently AltRank #1,154 based on combined combined social and market metrics
Daily Average: [-----]
[--] Week: [-----] +1,184
[--] Month: [-----] +505
[--] Months: [-----] +742
[--] Year: [-----] +1,020
1-Year High: [-----] on 2026-02-06
1-Year Low: [--] on 2025-12-28
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
1-Year High: [--] on 2026-01-13
1-Year Low: [--] on 2026-01-16
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [-----] -74%
[--] Month: [------] +19%
[--] Months: [-------] +57%
[--] Year: [-------] -4.50%
1-Year High: [------] on 2025-11-25
1-Year Low: [--] on 2025-09-14
Engagements by network (24h): News: [--] Reddit: [--] TikTok: [--] X: [---] YouTube: [--]
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] +9.10%
[--] Month: [---] +76%
[--] Months: [-----] +23%
[--] Year: [-----] +172%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-09-14
Mentions by network (24h): News: [--] Reddit: [--] TikTok: [--] X: [--] YouTube: [--]
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Arcus Biosciences, Inc. (RCUS) in the last [--] hours which is up 29% from [--] in the previous [--] hours
Daily Average: [--]
[--] Week: [--] +9.40%
[--] Month: [---] +31%
[--] Months: [---] -38%
[--] Year: [-----] +201%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-09-14
Sentiment 24-Hour Time-Series Raw Data
Current Value: 75%
Daily Average: 75%
[--] Week: 100% +50%
[--] Month: 50% +22%
[--] Months: 50% -38%
[--] Year: 50% -50%
1-Year High: 100% on 2025-02-15
1-Year Low: 3% on 2025-12-07
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00225%
Daily Average: 0.00474%
[--] Week: 0.0089% +0.0085%
[--] Month: 0.0031% -0.0012%
[--] Months: 0.0031% -0.0056%
[--] Year: 0.0031% -0.001%
1-Year High: 0.032% on 2025-06-28
1-Year Low: 0.0002% on 2025-09-14
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00265%
Daily Average: 0%
1-Year High: 0.12% on 2026-02-06
1-Year Low: 0.00265% on 2026-02-14
Market Cap 24-Hour Time-Series Raw Data
Current Value: $2,340,943,901
Daily Average: $2,795,082,619
[--] Week: $2,338,469,330 -10%
[--] Month: $2,340,943,901 -13%
1-Year High: $3,229,314,790 on 2025-11-28
1-Year Low: $2,340,943,901 on 2026-02-13
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$rcus